Cas:17329-24-7 6-amino-2-methyl-1H-quinazolin-4-one manufacturer & supplier

Chemical Name:6-amino-2-methyl-1H-quinazolin-4-one

CAS.NO:17329-24-7

Synonyms:6-amino-3,4-dihydro-2-methyl-4-oxoquinazoline;2-methyl-6-amino-4-oxoquinazoline;6-Amino-2-methyl-3H-chinazolin-4-on;6-amino-2-methyl-4(3H)-quinazolinone;6-amino-2-methylquinazolin-4-ol;6-amino-2-methyl-3H-quinazolin-4-one

Molecular Formula:C₉H₉N₃O

Molecular Weight:175.18700

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:72.03000

Exact Mass:175.07500

LogP:1.80720

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 6-amino-3,4-dihydro-2-methyl-4-oxoquinazoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-amino-2-methyl-3H-quinazolin-4-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-amino-2-methyl-3H-quinazolin-4-one Use and application,6-Amino-2-methyl-3H-chinazolin-4-on technical grade,usp/ep/jp grade.

Related News: Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. 6-amino-2-methyl-1H-quinazolin-4-one manufacturer A November 2020 analysis by researchers at the University of Oxford found Innova’s tests could be more or less accurate depending on who was using them—ranging from lab scientists to trained healthcare professionals to the general public—but determined the tests overall had a low failure rate and high specificity, despite some variations seen in production batches. Still, Innova’s test and antigen diagnostics more broadly have been seen as less accurate compared to gold-standard, lab-based PCR screening. 6-amino-2-methyl-1H-quinazolin-4-one supplier An effective treatment for Alzheimer��s, which is estimated in 60%-70% of around 50 million dementia cases worldwide, could become one of the best-selling drugs globally. 6-amino-2-methyl-1H-quinazolin-4-one vendor These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders �� in addition to Ed Damiano �� include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible. 6-amino-2-methyl-1H-quinazolin-4-one factory Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors.